NRx Pharmaceuticals Statistics
Total Valuation
NRXP has a market cap or net worth of $24.93 million. The enterprise value is $30.39 million.
Market Cap | 24.93M |
Enterprise Value | 30.39M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NRXP has 10.70 million shares outstanding. The number of shares has increased by 33.17% in one year.
Shares Outstanding | 10.70M |
Shares Change (YoY) | +33.17% |
Shares Change (QoQ) | +9.69% |
Owned by Insiders (%) | 26.67% |
Owned by Institutions (%) | 3.52% |
Float | 7.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
Current Ratio | 0.18 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -72.25 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -233.00% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$12.82M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.03% in the last 52 weeks. The beta is 1.26, so NRXP's price volatility has been higher than the market average.
Beta (5Y) | 1.26 |
52-Week Price Change | -43.03% |
50-Day Moving Average | 3.04 |
200-Day Moving Average | 3.72 |
Relative Strength Index (RSI) | 39.22 |
Average Volume (20 Days) | 73,885 |
Short Selling Information
The latest short interest is 301,666, so 2.82% of the outstanding shares have been sold short.
Short Interest | 301,666 |
Short Previous Month | 357,212 |
Short % of Shares Out | 2.82% |
Short % of Float | 3.86% |
Short Ratio (days to cover) | 2.60 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.40M |
Pretax Income | -25.64M |
Net Income | -25.65M |
EBITDA | -25.28M |
EBIT | -25.29M |
Earnings Per Share (EPS) | -$3.14 |
Balance Sheet
The company has $1.32 million in cash and $6.78 million in debt, giving a net cash position of -$5.46 million or -$0.51 per share.
Cash & Cash Equivalents | 1.32M |
Total Debt | 6.78M |
Net Cash | -5.46M |
Net Cash Per Share | -$0.51 |
Equity (Book Value) | -15.07M |
Book Value Per Share | -1.41 |
Working Capital | -15.51M |
Cash Flow
In the last 12 months, operating cash flow was -$19.24 million and capital expenditures $1,000, giving a free cash flow of -$19.24 million.
Operating Cash Flow | -19.24M |
Capital Expenditures | 1,000 |
Free Cash Flow | -19.24M |
FCF Per Share | -$2.17 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NRXP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.17% |
Shareholder Yield | -33.17% |
Earnings Yield | -102.87% |
FCF Yield | -77.16% |
Analyst Forecast
The average price target for NRXP is $43.00, which is 1,745.49% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $43.00 |
Price Target Difference | 1,745.49% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Apr 2, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |